These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38850897)

  • 1. The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction.
    Giorgione V; Ramnarine S; Malik A; Bhide A
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():91-95. PubMed ID: 38850897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.
    Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sFlt-1/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow.
    Quezada MS; Rodríguez-Calvo J; Villalaín C; Gómez-Arriaga PI; Galindo A; Herraiz I
    Ultrasound Obstet Gynecol; 2020 Oct; 56(4):549-556. PubMed ID: 31840879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
    Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    BJOG; 2024 Jul; 131(8):1089-1101. PubMed ID: 38196326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
    Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
    Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
    Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Blood Angiogenic Factors and the Prediction of Critical Adverse Perinatal Outcomes Among Small-for-Gestational-Age Pregnancies.
    Swissa SS; Walfisch A; Yaniv-Salem S; Pariente G; Hershkovitz R; Szaingurten-Solodkin I; Shashar S; Beharier O
    Am J Perinatol; 2024 Jul; 41(9):1185-1194. PubMed ID: 35292946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum biomarkers of placental insufficiency at 24-28 weeks of pregnancy in relation to the risk of delivering small-for-gestational-age infant in Sylhet, Bangladesh: a prospective cohort study.
    Rahman S; Islam MS; Roy AK; Hasan T; Chowdhury NH; Ahmed S; Raqib R; Baqui AH; Khanam R
    BMC Pregnancy Childbirth; 2024 Jun; 24(1):418. PubMed ID: 38858611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does a sFlt-1/PlGF ratio result > 655 before 34 weeks' gestation necessitate preterm delivery within 2 days? A retrospective observational study.
    Siepen C; Brennecke S
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2371047. PubMed ID: 38926094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
    Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor.
    Rodríguez-Calvo J; Villalaín C; Gómez-Arriaga PI; Quezada MS; Herraiz I; Galindo A
    Ultrasound Obstet Gynecol; 2023 Feb; 61(2):181-190. PubMed ID: 36370447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes.
    Bednarek-Jędrzejek M; Kwiatkowski S; Ksel-Hryciów J; Tousty P; Nurek K; Kwiatkowska E; Cymbaluk-Płoska A; Torbé A
    J Perinat Med; 2019 Sep; 47(7):732-740. PubMed ID: 31339858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.